Eczema Patients Have Lost Faith In Treatment: Survey

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2022-09-13 HKT 20:53

Share this story

facebook

  • Eczema patients have lost faith in treatment: survey

A international survey has found that only 37 percent of eczema patients in the city are working on treatment plans with doctors, while two-thirds have lost hope.

GlobalSkin, an international alliance of dermatology patient organisations, initiated the study covering 330 eczema patients in the SAR, South Korea and Australia in August, with one-third of the respondents in Hong Kong.

Dermatologist Dr Johnny Chan said on Tuesday that the proportion of patients in the city seeking medical advice is “very low”.

He said more than 90 percent of them are being treated by public practitioners, but strained medical resources due to the Covid-19 pandemic have delayed their treatment.

“The queue time of every [eczema] treatment will be two to three years at the moment," he said, adding that does not taken into account the impact Covid has had on waiting times even longer.

“While they are waiting, they think the treatments will not be helping them, and may lose the faith in treatment. They think it’s just incurable, they don’t want to have any treatment anymore,” Chan said.

“Public doctors have a limited time to see a lot of patients every day."

But for moderate to severe cases, he said, "they need some more time for explanations about the disease nature: to have a more tailor-made treatment plan for the patients, and to explain any possible side effects and the way to avoid these side effects.”

Chan added that less than 10 percent of eczema sufferers had sought treatment from the private sector. He said high costs was "very much an issue" here, with 72 percent of patients saying the heavy financial burden had deterred them from visiting doctors.

Dr Marco Ho, who chairs the Hong Kong Allergy Association, said when treatment is delayed, a patients’ immune system further deregulates and their conditions worsen, hence their expectations in consultations can be over-optimistic.

“Sometimes you don’t have the best-matched medication treatment as well as therapies. They have a whole lot of ideas and their own personal belief, so end up when we say ‘control’, they say ‘cure’; when we say ‘short-term gain’, they want a ‘long-term' remission,” he said.

“At times we even think the patient needs hospitalisation [but] they can't afford to stop their work or school.”

To clear up such misinterpretations and handle mental problems when patients are suffering from skin conditions, the allergy association and a concern group under the Hong Kong Health Care Alliance launched a free online counseling service on Tuesday that will run for three months.

RECENT NEWS

SBI Holdings To Acquire Bitbank In US$289M Crypto Expansion

SBI Holdings has agreed to acquire Japanese crypto exchange Bitbank in a deal valued at approximately US$289 million, w... Read more

4 Ways Hong Kong Banks Fight Financial Crime Using AI, According To HKMA

The Hong Kong Monetary Authority (HKMA) wants banks to use AI in financial crime as a way to counter cyberattacks and s... Read more

Ripple Launches RLUSD Stablecoin In Japan Through SBI Group

Ripple has launched its US dollar-denominated stablecoin, Ripple USD, in the Japanese market. The expansion follows reg... Read more

SBI And Startale Launch Trust Bank-Backed Yen Stablecoin JPYSC In Japan

SBI Group has introduced its trust based stablecoin JPYSC in partnership with Singapore-based fintech company Startale ... Read more

Visa Study: Digital Wallets Lead Greater Bay Area Payment Preferences

Visa has released its latest Consumer Payment Attitudes Study, highlighting how payment seamlessness is linked to a shi... Read more

European And South Korean Banks Form Project Pangea For FX Settlement

Chainlink, South Korean infrastructure provider FairSquareLab, the Unified Korea Alliance (UniKA), and European stablec... Read more